Cosmetics CDMO Services in China

A cosmetics CDMO (Contract Development and Manufacturing Organization) combines development and manufacturing in one coordinated programme. Depending on scope, it can include formulation development, ingredient registration support, patent-filing support, a testing plan, regulatory documentation, production scale-up and commercial manufacturing. Some steps involve external laboratories, patent advisers or market filing parties, and those responsibilities are defined before work begins.

OEM manufactures a formula you own. ODM develops a formula for you from existing ingredients and technology. A CDMO programme can add ingredient documentation and registration support, IP planning with external advisers, a testing plan and regulatory documentation on top of formulation and production. Choose a CDMO when the project needs development and evidence work, not just manufacturing.

We can support it as part of a scoped project. For a new ingredient, we can coordinate technical documentation, safety data and market-specific regulatory assessment. In China that means registration or filing support; in the EU it means ingredient and finished-product compliance assessment, which is a different process. The outcome rests with the authority, and the applicant or responsible party is defined for each market.

IP and patent-filing support can be scoped with qualified external advisers. Ownership, permitted use, filing territories, costs and disclosure rights are agreed in writing before development starts. Whether a patent is granted is decided by the patent office, not by us or the adviser.

CDMO projects are longer-term than standard manufacturing because they include research and registration. A full engagement, from new ingredient or formulation development through regulatory filing to commercial production, generally spans several months to over a year depending on scope. We propose a detailed development roadmap after assessing your requirements.

CDMO is best suited to brands, ingredient companies, and investors pursuing a differentiated formula or new technology, where the investment in development, evidence and IP planning is justified by long-term differentiation. Emerging brands seeking speed and low cost are usually better served by our private label or ODM services.

Include the product concept, intended claims, target markets, active or delivery-system requirement, any formula or IP already owned, expected volume, launch window, and the reports or filings you expect. Those inputs let us separate development, manufacturing and external work before quoting.

The written scope should identify milestones, deliverables, approval gates, formula and IP ownership, in-house and external responsibilities, testing and documentation, and commercial-production assumptions. Any external laboratory, patent adviser or market filing party is named by role before work begins.